Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 1, 2019
Reporting Period: Single event date (August 1, 2019)
Business Context: The filing serves as a Regulation FD disclosure to announce a scheduled presentation by the Company's CEO at an industry summit.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
There are no material financial changes reported in this document. The sole material event is the announcement of a corporate presentation.
Guidance, Outlook, and Management Commentary
- Event Announcement: RJ Tesi, M.D., co-founder and CEO, is scheduled to present at the Cambridge Healthcare Institute's 7th Annual Immuno-Oncology Summit.
- Event Details: The summit is taking place in Boston from August 5 through August 9, 2019.
- Exhibit Status: The press release detailing this event is furnished as Exhibit 99.1 but is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the content of the press release (Exhibit 99.1) for specific details regarding the CEO's presentation.
- Confirm the dates and location of the Cambridge Healthcare Institute's 7th Annual Immuno-Oncology Summit.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.